Why the study?
Anticoagulated patients have a propensity to bleed, and reversal recommendations are constantly evolving with the development of specific reversal agents.
This review summarizes currently recommended strategies for emergency department providers to manage bleeding and reverse anticoagulation or antiplatelet therapy.
Emergency clinicians need current reversal protocols for bleeding; leaves open comparative outcome data on specific agents.
Owing to the propensity of anticoagulated patients to bleed, a strategy for reversal of anticoagulation induced by any of the common agents is essential. Many patients are anticoagulated with a variety of agents, including warfarin, low molecular weight heparin, and the direct oral anticoagulants such as factor Xa and factor IIa inhibitors. Patients may also be using antiplatelet agents. Recommendations to reverse bleeding in these patients are constantly evolving with the recent development of specific reversal agents. A working knowledge of hemostasis and the reversal of anticoagulation and antiplatelet drugs is required for every emergency department provider. This article reviews these topics and presents the currently recommended strategies for dealing with bleeding in the anticoagulated patient.
No takes yet. Share an insight, caveat, or question.
Yee et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Dual antiplatelet therapyMore from Western Journal of Emergency Medicine